ArticleCost effectiveness and resource allocation : C/E2026
Individual-level prediction models of societal costs and health-related quality of life in pediatric cerebral palsy: a population-based study from Spain.
Article in Cost effectiveness and resource allocation : C/E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndividual-level economic models more effectively capture the heterogeneity of clinical severity, caregiving needs, and social context in pediatric cerebral palsy (CP). We developed and validated predictive models to estimate how clinical, sociodemographic, socioeconomic, and health-related quality-of-life (HRQoL) factors affect disaggregated categories of societal costs. We then examined how these factors and cost components influence HRQoL outcomes for children with CP and their caregivers in Spain.
methodsUsing data from 148 children with CP and their caregivers in a Spanish population-based registry, we estimated annual costs from a societal perspective. Cost components included healthcare, informal care, public subsidies, and out-of-pocket expenses (adjusted to €2023). We applied generalized linear models (GLMs) to model costs: one-part GLMs with gamma distribution and log link for most categories, and two-part models for intensive rehabilitation therapies (logistic regression for the probability of any cost, followed by a GLM for the positive costs). Child and caregiver HRQoL were modelled using ordinary least squares (OLS) and Tobit regression, respectively. Predictive performance was assessed via mean absolute error (MAE), root mean squared error (RMSE), and mean error (ME).
resultsGreater functional impairment in children was the primary driver of higher costs and lower HRQoL. Socioeconomic factors, including caregivers' job loss due to caregiving, low household income, and lower social class, predicted higher out-of-pocket spending and worse caregiver HRQoL. Latin American family origin was associated with higher total illness costs but lower informal care costs. Use of non-standard therapies (reported by 64% of families) increased overall societal costs and was linked to marginally better child HRQoL.
conclusionsIndividual-level, disaggregated models can inform value-based healthcare assessments by capturing the complexity of pediatric disability. Our findings underscore the importance of caregiver burden and informal care in determining costs and well-being. We provide a web-based Shiny calculator to enable practical application of these predictive models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.